Royalty payments and Canada's Access to Medicines Regime
A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2020-09-17
Data overview
- Formats
- HTML
- File languages
- English, French